Acyclovir: Difference between revisions

Revision as of 22:24, 4 March 2015

Varicella
- Immunocompetent
  - 800 mg PO QID x 5-7 d
- Immunocompromised
  - 10 mg/kg IV q8h x 7 d
Herpes Zoster
- Immunocompetent
  - 800 mg PO 5x/day x 7 d
- Immunocompromised
  - 10 mg/kg IV q8h x 7 d

Authors:

@@ Line 5: / Line 5: @@
 ==Adult Dosing==
+*HSV Encephalitis
+**10 mg/kg IV q8h x 10 d
+*Genital/Mucocutaneous HSV
+**Immunocompetent
+***1st episode, Mild-mod: 400 mg PO TID x 7-10 d
+***1st episode, Severe: 5-10 mg/kg IV q8h x 2-7 d
+***Recurrence: 400 mg PO TID x 5 d
+***Suppression: 400 mg PO BID
+**Immunocompromised
+***1st episode: 400 mg PO TID x 5-10 d
+***Recurrence: 400 mg PO TID x 5-10 d
+***Suppression: 400-800 mg PO BID-TID
+*Varicella
+**Immunocompetent
+***800 mg PO QID x 5-7 d
+**Immunocompromised
+***10 mg/kg IV q8h x 7 d
+*Herpes Zoster
+**Immunocompetent
+***800 mg PO 5x/day x 7 d
+**Immunocompromised
+***10 mg/kg IV q8h x 7 d
+*Zoster Ophthalmicus
+**800 mg PO 5x/day x 7 d
+*HSV prophylaxis in immunocompromised
+**400-800 mg PO BID-TID
+*HSV keratitis
+**400 mg PO 5x/day
 ==Pediatric Dosing==